CureVac says in talks with potential vaccine development partners
CureVac is still in discussions with pharma majors to find a potential partner for its experimental COVID-19 vaccine, the German biotech firm's chief executive said on Thursday. Haas said the group was close to launching a Phase III trial with about 36,000 participants to find out whether its vaccine

Full story is loading. Click here if it doesn't...